Skip to content

H2020FP7HORIZON

Astrazeneca AB

Country
SESweden
Defence projects
0
Projects, all programmes
150
As coordinator
8
EU contribution (CORDIS)
EUR 17,186,814
Active
2008 to 2026

Projects

150 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
OPEN PHACTSThe Open Pharmacological Concepts Triple StoreFP72011ParticipantNot stated
SCR&TOXStem Cells for Relevant Efficient Extended and Normalized ToxicologyFP72011ParticipantEUR 226,937
DDMOREDrug Disease Model ResourcesFP72011ParticipantNot stated
QUIC-CONCEPTQUantitative Imaging in Cancer: CONnecting CEllular Processes with TherapyFP72011ParticipantNot stated
EHR4CRElectronic Health Record systems for Clinical ResearchFP72011CoordinatorNot stated
PREDECTNew Models for Preclinical Evaluation of Drug Efficacy in Common Solid TumoursFP72011ParticipantNot stated
BTCUREBeTheCuREFP72011ParticipantNot stated
POWTECHIntegrating research training in particle & powder technology to deliver efficient products with high functionalityFP72011ParticipantEUR 246,098
ONCOTRACKOncoTrack - Methods for systematic next generation oncology biomarker developmentFP72011ParticipantNot stated
Π-NETPulmonary Imaging NetworkFP72010ParticipantEUR 263,205
IMIDIAImproving beta-cell function and identification of diagnostic biomarkers for treatment monitoring in diabetesFP72010ParticipantNot stated
SAFESCIMETEuropean Modular Education and Training Programme in Safety Sciences for MedicinesFP72010ParticipantNot stated
ARITMOArrhythmogenic potential of drugsFP72010ParticipantEUR 101,465
PHARMA-COGPrediction of cognitive properties of new drug candidates for neurodegenerative diseases in the early clinical developmentFP72010ParticipantNot stated
ETOXIntegrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicitiesFP72010ParticipantNot stated
PRO- ACTIVEPhysical Activity as a Crucial Patient Reported Outcome in COPDFP72009ParticipantNot stated
U-BIOPREDUnbiased Biomarkers for the Prediction of Respiratory Disease OutcomesFP72009ParticipantNot stated
EMTRAINEuropean Medicines Research Training NetworkFP72009CoordinatorNot stated
SUMMITSUrrogate markers for vascular Micro- and Macrovascular hard endpoints for Innovative diabetes ToolsFP72009ParticipantNot stated
NEWMEDSNovel Methods leading to New Medications in Depression and SchizophreniaFP72009ParticipantNot stated

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.